We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Proteomic System Will Further Biomarker Research

By Biotechdaily staff writers
Posted on 03 May 2007
A new instrument system and software have been designed to assist the growing number of life scientists involved in biomarker research.

The study of protein biomarkers is important to life scientists because the identification of biomarkers can indicate the presence and progression of a variety of diseases or response to drugs. More...
Central to this research is the science of proteomics through which thousands of proteins in a biologic sample--e.g., tissues, cells, serum, urine, cerebrospinal fluid--can be analyzed in the same experiment to obtain a snapshot of the proteome. To discover new biomarker candidates, these snapshots need to be compared quantitatively against other samples, such as healthy versus diseased samples, so the complex differences that exist in biologic systems can be found and exploited.

The discovery of protein biomarkers requires large numbers of sample sets and simplified data output produced on proteomics research platforms. Much biomarker research is conducted by biologic scientists who are not necessarily proteomics experts. The new advances from Applied Biosystems (Foster City, CA, USA; www.appliedbiosystems.com) and its venture partner, MDS Scieux (Mississauga, Canada) are designed to enable non-expert instrument users to achieve higher throughput sample processing, greater depth of proteome coverage, greater statistical rigor, more confident protein detection, and better quantitative results.

Utilizing proteomics products from Applied Biosystems/MDS Sciex, a study identified 23 biomarker candidates that were associated with the presence of Alzheimer's disease, and may provide links to the pathologic mechanisms of the disease. The scientists involved in the study cited the discovery as a potential breakthrough. Currently, there are no definitive tests available for the diagnosis of the disease in living subjects, with confirmation of its existence normally being made after the death of a patient.

The 4800 Plus Maldi Tof/Tof analyzer is a proteomics analyzer that can identify thousands of proteins in a biologic sample. The enhancements from the previous version of the system provide an improved platform to better support the larger sample studies that proteomics researchers are moving towards, especially for biomarker discovery.

A new version of ProteinPilot software is designed to maximize the information that can be obtained from the combination of the 4800 Plus and Applied Biosystems iTraq reagents. It delivers more accurate protein detection, easier manageability, and broader support for quantitation, thereby providing greater confidence in the results.

These latest tools are designed to be compatible with the future commercial release of the 8-plex version of Applied Biosystems iTraq reagents, a labeling chemistry allowing scientists and biologists to quantitatively compare proteins between samples. The 8-plex version of these reagents is expected to increase the number of samples that can be compared simultaneously, providing higher throughput, better accuracy, and greater statistical confidence in research results.


Related Links:
Applied Biosystems
MDS Sciex

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.